NO793504L - PROCEDURE FOR THE PREPARATION OF 5,6,7,8-TETRAHYDRO-4 (3H) -KINAZOLINON DERIVATIVES - Google Patents

PROCEDURE FOR THE PREPARATION OF 5,6,7,8-TETRAHYDRO-4 (3H) -KINAZOLINON DERIVATIVES

Info

Publication number
NO793504L
NO793504L NO793504A NO793504A NO793504L NO 793504 L NO793504 L NO 793504L NO 793504 A NO793504 A NO 793504A NO 793504 A NO793504 A NO 793504A NO 793504 L NO793504 L NO 793504L
Authority
NO
Norway
Prior art keywords
formula
alkyl
tetrahydro
carbon atoms
derivatives
Prior art date
Application number
NO793504A
Other languages
Norwegian (no)
Inventor
Zoltan Ecsery
Judit Hermann
Zoltan Toeroek
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of NO793504L publication Critical patent/NO793504L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/90Oxygen atoms with acyclic radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Description

Fremgangsmåte ved fremstilling au 5,6,7,8-tetrahydro-4(3H)-kinazolinonderivater Procedure for the preparation of 5,6,7,8-tetrahydro-4(3H)-quinazolinone derivatives

Foreliggende oppfinnelse angår en fremgangsmåte ved fremstilling av nye terapeutisk aktive 5,6,7,8-tetrahydro-4(3H)-kinazolinon-derivater. The present invention relates to a method for the production of new therapeutically active 5,6,7,8-tetrahydro-4(3H)-quinazolinone derivatives.

Fremgangsmåtetorbindelsene ifølge foreliggende oppfinnelse har den generelle formel: The process compounds according to the present invention have the general formula:

hvor where

R er hydrogen eller alkyl med 1-5 carbonatomer,R is hydrogen or alkyl with 1-5 carbon atoms,

R 2 er alkyl med 1-5 carbonatomer, aryl eller aryl substituert med alkyl med 1-5 carbonatomer, og/eller halogen, R 2 is alkyl with 1-5 carbon atoms, aryl or aryl substituted with alkyl with 1-5 carbon atoms, and/or halogen,

og salter derav.and salts thereof.

Uttrykket "alkyl" er anvendt for å betegne rettkjedede eller forgrenede alkylgrupper med 1 til 5, fortrinnsvis 1 til 4, carbonatomer. The term "alkyl" is used to denote straight chain or branched alkyl groups with 1 to 5, preferably 1 to 4, carbon atoms.

Uttrykket aryl er her anvendt for å betegne fenyl eller nafthyl, fortrinnsvis fenyl. The term aryl is used here to denote phenyl or naphthyl, preferably phenyl.

Uttrykket halogen omfatter klor, brom, fluor og jod, idet klor og brom er de foretrukne halogener. The term halogen includes chlorine, bromine, fluorine and iodine, chlorine and bromine being the preferred halogens.

Saltene av forbindelsene med formel (I) kan dannes med uorganiske eller organiske syrer, som saltsyre, hydrogenbromid, svovelsyre, maleinsyre, vinsyre og fumarsyre. The salts of the compounds of formula (I) can be formed with inorganic or organic acids, such as hydrochloric acid, hydrogen bromide, sulfuric acid, maleic acid, tartaric acid and fumaric acid.

Foreliggende oppfinnelse angår en fremgangsmåte ved fremstilling av forbindelsene med formel (I) og salter derav, som kjennetegnes ved at The present invention relates to a method for the preparation of the compounds of formula (I) and salts thereof, which are characterized in that

a) .et amin med formelen:a) .an amine with the formula:

hvor R 2er som ovenfor angitt, eller et salt derav, omsettes med cyclohexencarboxylsyrederivater med formelen: eller benzoxazinonderivater med formelen: where R 2 is as indicated above, or a salt thereof, is reacted with cyclohexenecarboxylic acid derivatives of the formula: or benzoxazinone derivatives of the formula:

hvor where

R"*" er som ovenfor angitt, ogR"*" is as above indicated, and

R 3 er hydrogen eller alkyl med 1-5 carbonatomer, eller R 3 is hydrogen or alkyl with 1-5 carbon atoms, or

b) et alkyl-2-oxo-cyclohexan-carboxylat med formelen: b) an alkyl-2-oxo-cyclohexane carboxylate of the formula:

hvor where

R 5 er alkyl med 1-5 carbonatomer, omsettes med et amidinderivat med formelen: R 5 is alkyl with 1-5 carbon atoms, is reacted with an amidine derivative with the formula:

12 12

hvor R og R er som ovenfor angitt, eller med et salt derav, og, om ønskes, overføres forbindelsene med formel (I) til deres uorganiske eller organiske salter. wherein R and R are as above, or with a salt thereof, and, if desired, the compounds of formula (I) are converted into their inorganic or organic salts.

Forbindelsene med formel (I) er ikke spesielt beskrevet i litteraturen, men noen av dem omfattes av den generelle formel angitt i belgisk patent 620 379. The compounds of formula (I) are not particularly described in the literature, but some of them are covered by the general formula stated in Belgian patent 620 379.

I henhold til en fremgangsmåte angitt i belgisk patent 620 379 omsettes 3-amino-crotonsyredérivater med carboxylsyrer eller med iminoetherderivater derav, og 2,3,6-trisubstituert-4-pyrimidonderivater fåes. According to a method stated in Belgian patent 620 379, 3-amino-crotonic acid derivatives are reacted with carboxylic acids or with iminoether derivatives thereof, and 2,3,6-trisubstituted-4-pyrimidone derivatives are obtained.

På analogt vis fåes ved omsetning av l-carboxy-2-amino-cyclohexenderivater med iminoetherderivater av carboxylsyrer, forbindelser med formel (I). Analogously, by reacting l-carboxy-2-amino-cyclohexene derivatives with iminoether derivatives of carboxylic acids, compounds of formula (I) are obtained.

De kjente 5,6,7,8-tetrahydro-4(3H)-kinazolinonderivater fremstilles ved å omsette carbethoxy-cyclohexanon med amidin, med et utbytte på 38 til 54% [J. Am. Chem. Soc. 80, 6609 (1958)]. Nye kinazolinderivater ifølge foreliggende oppfinnelse kan også fremstilles ved å følge denne fremgangsmåte, som beskrevet i variant b) av den krevede fremgangsmåte. The known 5,6,7,8-tetrahydro-4(3H)-quinazolinone derivatives are prepared by reacting carbethoxycyclohexanone with amidine, with a yield of 38 to 54% [J. Am. Chem. Soc. 80, 6609 (1958)]. New quinazoline derivatives according to the present invention can also be prepared by following this method, as described in variant b) of the claimed method.

I henhold til en foretrukken utførelsesform av fremgangsmåtevariant a) fremstilles forbindelsene med formel (I) ved å omsette 2-acylamino-cyclohexencarboxylsyrer.eller carboxylsyrederivater med formel (III) med aminer med formelen (II). Hoved-fordelen ved denne fremgangsmåte ligger i det forhold at den kan utføres med et høyt (ca. 80%) utbytte, og substituentene i 2- og 3-stillingene kan velges éfter ønske. According to a preferred embodiment of method variant a), the compounds of formula (I) are prepared by reacting 2-acylamino-cyclohexenecarboxylic acids or carboxylic acid derivatives of formula (III) with amines of formula (II). The main advantage of this method lies in the fact that it can be carried out with a high (approx. 80%) yield, and the substituents in the 2- and 3-positions can be chosen as desired.

Forbindelsene med formel (III) er også nye og kan fremstilles ved å acylere 2-amino-cyclohexen-carboxylsyreestere The compounds of formula (III) are also new and can be prepared by acylating 2-amino-cyclohexene-carboxylic acid esters

[Liebig's Ann. 317, 100 (190.1);. Am. Chem. Soc. 78, 2873 (1956)][Liebig's Ann. 317, 100 (190.1);. Am. Chem. Soc. 78, 2873 (1956)]

og underkaste de erholdte acylamino-cyclohexen-carboxylsyreestere selektiv hydrolyse, som vist ved ligningen: and subjecting the obtained acylamino-cyclohexene-carboxylic acid esters to selective hydrolysis, as shown by the equation:

I henhold til en mere foretrukken utførelsesform av fremgangsmåtevariant a), omsettes forbindelsene med formelen (III) med forbindelser med formel (II) i nærvær, av et surt dehydratiseringsmiddel, som thionylklorid, og reaksjonen fullføres fortrinnsvis ved oppvarmning. According to a more preferred embodiment of method variant a), the compounds of formula (III) are reacted with compounds of formula (II) in the presence of an acidic dehydrating agent, such as thionyl chloride, and the reaction is preferably completed by heating.

Reaksjonen kan utføres i et oppløsningsmiddel eller i fravær av et oppløsningsmiddel, ved å blande reaktantene. Som oppløsningsmiddel anvendes fortrinnsvis med vann ublandbare oppløsningsmidler, som benzen, toluen, xylen, bensin eller kloroform, men reaksjonen kan også utføres i med vann blandbare oppløsningsmidler som eddiksyre eller alkohol. The reaction can be carried out in a solvent or in the absence of a solvent, by mixing the reactants. Water-immiscible solvents such as benzene, toluene, xylene, petrol or chloroform are preferably used as solvents, but the reaction can also be carried out in water-miscible solvents such as acetic acid or alcohol.

Ved nok en annen foretrukken utførelsesform av fremgangsmåtevariant a) omsettes forbindelser med formelen (III) med aminer med formelen (II) i nærvær av organiske eller mineral-syrer, eller salter av aminene anvendes i denne reaksjon. Reaksjonen kan utføres i fravær av oppløsningsmiddel eller i et hvilket som helst av de ovennevnte oppløsningsmidler. In yet another preferred embodiment of method variant a), compounds of the formula (III) are reacted with amines of the formula (II) in the presence of organic or mineral acids, or salts of the amines are used in this reaction. The reaction may be carried out in the absence of solvent or in any of the above solvents.

Ved en annen utførelsesform av fremgangsmåtevariant a) omsettes 5,6,7,8-tetrahydro-4H-3,l-benzoxazin-4-on-derivater med formelen (IV) med aminer med formelen (II) eller med saltene derav. Reaksjonen kan eventuelt utføres i nærvær av et kondens-eringsmiddel i et passende oppløsningsmiddel, eller uten oppløs-ningsmiddel ved å smelte reaktantene. 5,6,7,8-tetrahydro-4H-3,1-benzoxazin-4-on-derivatene som anvendes som utgangsmaterialer, er nye og kan f.eks. fremstilles fra 2-acylamino-cyclohexen-carboxylsyrer med dehydratiseringsmidler, som fosforoxyklorid, eddiksyreanhydrid, dicyclohexy1-carbodiimid. In another embodiment of method variant a), 5,6,7,8-tetrahydro-4H-3,1-benzoxazin-4-one derivatives of the formula (IV) are reacted with amines of the formula (II) or with their salts. The reaction can optionally be carried out in the presence of a condensing agent in a suitable solvent, or without a solvent by melting the reactants. The 5,6,7,8-tetrahydro-4H-3,1-benzoxazin-4-one derivatives used as starting materials are new and can e.g. are prepared from 2-acylamino-cyclohexene-carboxylic acids with dehydrating agents, such as phosphorus oxychloride, acetic anhydride, dicyclohexy1-carbodiimide.

Ved variant b) av fremgangsmåten ifølge oppfinnelsen omsettes alkyl-2-oxo-cyclohexan-carboxylater med formelen (V) med amidiner med formelen (VI). Reaksjonen kan utføres i et oppløs-ningsmiddel som alkohol, benzen, toluen, tetrahydrofuran, dioxan, eller uten oppløsningsmiddel ved å blande reaktantene. Reaksjonen kan føres til fullstendighet ved oppvarmning. Amidiner med formel (VI) kan anvendes i form av baser eller salter. Hvis saltene av amidinene anvendes, kan baser også være tilstede for å eliminere syrene som er blitt anvendt ved fremstilling av salter. Foretrukne baser er' alkalialkoholater. In variant b) of the method according to the invention, alkyl-2-oxo-cyclohexane carboxylates of the formula (V) are reacted with amidines of the formula (VI). The reaction can be carried out in a solvent such as alcohol, benzene, toluene, tetrahydrofuran, dioxane, or without a solvent by mixing the reactants. The reaction can be brought to completion by heating. Amidines of formula (VI) can be used in the form of bases or salts. If the salts of the amidines are used, bases may also be present to eliminate the acids that have been used in making the salts. Preferred bases are alkali alcoholates.

Reaksjonsblandingen erholdt ved å følge en hvilken som helst av fremgangsmåtevariantene ifølge oppfinnelsen, gjøres alkalisk med alkali- eller jordalkalihydroxyder eller -carbon-ater, og oppløsningsmidlet elimineres ved destillasjon eller blandingen underkastes dampdestillasjon. Dampdestillasjon er særlig fordelaktig hvis vannuoppløselige uomsatte aminer skal fjernes.. Når dampdestillasjonen er avsluttet, blir produktene, hvis de erholdes i en ikke-krystallinsk form, fraskilt ved ekstraksjon med et oppløsningsmiddel og påfølgende inndampning. The reaction mixture obtained by following any of the process variants according to the invention is made alkaline with alkali or alkaline earth hydroxides or carbonates, and the solvent is eliminated by distillation or the mixture is subjected to steam distillation. Steam distillation is particularly advantageous if water-insoluble unreacted amines are to be removed. When the steam distillation is finished, the products, if obtained in a non-crystalline form, are separated by extraction with a solvent and subsequent evaporation.

Produktene kan eventuelt renses ved krystallisasjon. The products can optionally be purified by crystallization.

Forbindelsene med formel (I) kan overføres til deres uorganiske eller organiske salter ved i og for seg kjente metoder. Visse syrer som kan anvendes eller danne salter, er nevnt ovenfor som eksempler. The compounds of formula (I) can be converted to their inorganic or organic salts by methods known per se. Certain acids which can be used or form salts are mentioned above as examples.

Forbindelsene med formel (I) har nyttige terapeutiske egenskaper og oppviser spasmolytisk virkning. The compounds of formula (I) have useful therapeutic properties and exhibit spasmolytic action.

Fremgangsmåteforbindelsene kan opparbeides til farmasøyt-iske preparater som omfatter som aktiv bestanddel en forbindelse med formel (I) eller et farmakologisk godtagbart, ikke-giftig salt derav, i blanding med passende faste eller flytende bærere eller fortynningsmidler. Preparatene kan opparbeides i fast form, som f.eks. tabletter, stikkpiller, pulverblandinger, eller i flytende form som oppløsninger eller suspensjoner. The method compounds can be processed into pharmaceutical preparations which comprise as active ingredient a compound of formula (I) or a pharmacologically acceptable, non-toxic salt thereof, in admixture with suitable solid or liquid carriers or diluents. The preparations can be prepared in solid form, such as e.g. tablets, suppositories, powder mixtures, or in liquid form as solutions or suspensions.

Som bærere kan konvensjonelle bærere anvendes. As carriers, conventional carriers can be used.

Preparatene kan eventuelt inneholde vanlige tilsetninger som smøremidler og fyllstoffer. The preparations may possibly contain common additives such as lubricants and fillers.

Administrasjonen kan skje oralt, parenteralt eller enter-alt.. The administration can take place orally, parenterally or enterally.

Den spasmolytiske virkning av forbindelsene med formel (I) er ikke ledsaget av sedativ eller narkotisk virkning. 2-methyl-3-o-tolyl-5 , 6 , 7 , 8-tetrahydro-4 (3H.) -kinazolinon inhiberer f.eks. The spasmolytic effect of the compounds of formula (I) is not accompanied by a sedative or narcotic effect. 2-methyl-3-o-tolyl-5, 6, 7, 8-tetrahydro-4 (3H)-quinazolinone inhibits e.g.

i en dose på 100 mg/kg, kramper fremkalt av Tetracor uten å utøve en narkotisk virkning. På den annen side har f.eks. fenyl-ethyl-barbitursyre ("Sevenal") og difenyl-hidantoin ("biphedan") som er velkjente kommersielle spasmolytiske preparater, en sterk narkotisk virkning i den samme dose. in a dose of 100 mg/kg, convulsions induced by Tetracor without exerting a narcotic effect. On the other hand, e.g. phenyl-ethyl-barbituric acid ("Sevenal") and diphenyl-hydantoin ("biphedan") which are well-known commercial spasmolytic preparations, a strong narcotic effect in the same dose.

En annen anvendelse av forbindelsene med formel (I) er at de kan overføres til 4(4H)-kinazolinonderivater ved dehydrogen-ering, og blant de. sistnevnte forbindelser er flere kjente terapeutisk aktive forbindelser (f.eks. 2-methyl-3-o-tolyl- 4(3H)-kinazolinon som markedsføres som "Mathaqualone" til narkotiske formål). . Videre detaljer om foreliggende oppfinnelse vil finnes i eksemplene uten å begrense omfanget av oppfinnelsen til eksemplene. Another application of the compounds of formula (I) is that they can be transferred to 4(4H)-quinazolinone derivatives by dehydrogenation, and among those. the latter compounds are several known therapeutically active compounds (eg 2-methyl-3-o-tolyl-4(3H)-quinazolinone which is marketed as "Mathaqualone" for narcotic purposes). . Further details of the present invention will be found in the examples without limiting the scope of the invention to the examples.

Eksempel 1Example 1

9,3 g 2-acetamido-cyclohexen-carboxylsyre suspenderes i9.3 g of 2-acetamido-cyclohexene-carboxylic acid are suspended in

90 ml toluen, og efter tilsetning av 12,5 ml anilin tilsettes 3,43 g fosfortriklorid i 20 ml toluen til blandingen dråpevis under omrøring. Reaksjonsblandingen kokes under tilbakeløp i ytterligere 3 timer under omrøring. Efter avkjøling tilsettes 100 ml 20%-ig vandig natriumcarbonatoppløsning, og blandingen underkastes dampdestillasjon. Dampdestillasjon fortsettes inntil oljedråper iakttaes i destillatet. Som destillasjonsrest fåes en alkalisk, vandig oppløsning av et krystalliserbart harpiksaktig produkt. Efter avkjøling frafUtreres produktet, vaskes nøytralt med vann og behandles med bensin for å fjerne rester av harpiks. Det tørres så til konstant vekt, hvorved.man får 9,71 g av et råprodukt som smelter ved 138 - 14 2°C. 90 ml of toluene, and after adding 12.5 ml of aniline, 3.43 g of phosphorus trichloride in 20 ml of toluene is added dropwise to the mixture while stirring. The reaction mixture is refluxed for a further 3 hours with stirring. After cooling, 100 ml of 20% aqueous sodium carbonate solution is added, and the mixture is subjected to steam distillation. Steam distillation is continued until oil droplets are observed in the distillate. An alkaline, aqueous solution of a crystallizable resinous product is obtained as a distillation residue. After cooling, the product is filtered, washed neutrally with water and treated with petrol to remove resin residues. It is then dried to constant weight, whereby 9.71 g of a crude product is obtained which melts at 138 - 142°C.

Krystallisasjon fra en 1:1 (volum) blanding av benzen og bensin gir 2-methyl-3-fenyl-5,6,7,8-tetrahydro-4(3H)-kinazolinon som smelter ved 154 - 155°C. Crystallization from a 1:1 (by volume) mixture of benzene and gasoline gives 2-methyl-3-phenyl-5,6,7,8-tetrahydro-4(3H)-quinazolinone which melts at 154 - 155°C.

Eksempel 2 Example 2

9,3 g 2-acetamido-cyclohexencarboxylsyre oppløses i 25 ml eddiksyre, og til den dannede oppløsning tilsettes 5,5 ml p-toluidin og 1 ml fosfortriklorid. Reaksjonsblandingen kokes under tilbakeløp med omrøring i 3 timer. Eddiksyre avdestilleres i vakuum, og residuet gjøres alkalisk med en 20%-ig vandig natriumcarbonatoppløsning. Den fraskilte harpiks ekstraheres med benzen, benzenoppløsningen tørres over natriumsulfat og inndampes. Man får 8,42 g av et residuum. Omkrystallisasjon fra en 1:1 blanding av benzen og bensin og avfarvning med aluminium-oxyd gir 2-methyl-3-o-.tolyl-4 (3H)-kinazolinon som smelter ved 150 - 153°C. 9.3 g of 2-acetamido-cyclohexenecarboxylic acid are dissolved in 25 ml of acetic acid, and 5.5 ml of p-toluidine and 1 ml of phosphorus trichloride are added to the resulting solution. The reaction mixture is refluxed with stirring for 3 hours. Acetic acid is distilled off in a vacuum, and the residue is made alkaline with a 20% aqueous sodium carbonate solution. The separated resin is extracted with benzene, the benzene solution is dried over sodium sulphate and evaporated. You get 8.42 g of a residue. Recrystallization from a 1:1 mixture of benzene and gasoline and decolorization with aluminum oxide gives 2-methyl-3-o-.tolyl-4 (3H)-quinazolinone which melts at 150 - 153°C.

Eksempel 3Example 3

Ved å følge fremgangsmåten i eksempel 2, men ved å gå ut fra 8 g 2-acetamido-cyclohexencarboxylsyre, 5,1 ml p-amino-ethylbenzen, .21,5 ml eddiksyre og 0,86 ml fosfortriklorid, fåes 9,9 g 2-methyl-3-p-ethylfenyl-5,6,7,8-tetrahydro-4(3H)-kinazolinon som smelter ved 128 - 131°C (efter omkrystallisasjon fra bensin). By following the procedure in example 2, but starting from 8 g of 2-acetamido-cyclohexenecarboxylic acid, 5.1 ml of p-amino-ethylbenzene, .21.5 ml of acetic acid and 0.86 ml of phosphorus trichloride, 9.9 g are obtained 2-methyl-3-p-ethylphenyl-5,6,7,8-tetrahydro-4(3H)-quinazolinone which melts at 128 - 131°C (after recrystallization from petrol).

Eksempel 4 Example 4

Ved å følge fremgangsmåten i eksempel 1, men ved å omsette 9,3 g 2-acetamido-cyclohexencarboxyIsyre og 16 g o-kloranilin i 90 ml toluen med en blanding av 2,18 g fosfortriklorid med 20 ml toluen, fåes 10,86 g 2-methyl-3-o-klorfenyl-5,6,7,8-tetrahydro-4(3H)-kinazolinon som smelter ved 123 - 128°C. Efter omkrystal-lisas jon fra en 1:1 blanding av benzen og bensin er smeltepunktet 130 - 132°C. By following the procedure in example 1, but by reacting 9.3 g of 2-acetamido-cyclohexenecarboxylic acid and 16 g of o-chloroaniline in 90 ml of toluene with a mixture of 2.18 g of phosphorus trichloride with 20 ml of toluene, 10.86 g are obtained 2-methyl-3-o-chlorophenyl-5,6,7,8-tetrahydro-4(3H)-quinazolinone melting at 123 - 128°C. After recrystallization from a 1:1 mixture of benzene and petrol, the melting point is 130 - 132°C.

Eksempel 5 Example 5

Ved å følge fremgangsmåten i eksempel 1, men ved å omsette 18,3 g 2-acetamido-cyclohexencarboxylsyre og. 35,4 g 5-klor-2-methylanilin i 180 ml toluen med en blanding av 4,36 ml fosforoxyklorid med 40 ml toluen, fåes 22,42 g 2-methyl-3-(2-methyl-5-klorfenyl)-5,6,7,8-tetrahydro-4(3H)-kinazolinon som smelter ved 126 - 128°C (efter omkrystallisasjon fra en 1:1 blanding av benzen og bensin). By following the procedure in example 1, but by reacting 18.3 g of 2-acetamido-cyclohexenecarboxylic acid and. 35.4 g of 5-chloro-2-methylaniline in 180 ml of toluene with a mixture of 4.36 ml of phosphorus oxychloride with 40 ml of toluene, 22.42 g of 2-methyl-3-(2-methyl-5-chlorophenyl)- 5,6,7,8-tetrahydro-4(3H)-quinazolinone melting at 126 - 128°C (after recrystallization from a 1:1 mixture of benzene and gasoline).

Eksempel 6 Example 6

Ved å følge fremgangsmåten i eksempel 1, men ved å omsette 18,3 g 2-acetamido-cyclohexencarboxylsyre og 35,4 g 4-klor-2-methylanilin i 180 ml toluen med en blanding av 4,36 ml fosfortriklorid og 40 ml toluen, fåes 16,48 g 2-methyl-3-(4-klor-2-methylfenyl)-5,6,7,8-tetrahydro-4(3H)-kinazolinon som smelter ved 151 - 153°C (efter omkrystallisajon fra en 1:1 blanding av benzen og bensin). By following the procedure in Example 1, but by reacting 18.3 g of 2-acetamido-cyclohexenecarboxylic acid and 35.4 g of 4-chloro-2-methylaniline in 180 ml of toluene with a mixture of 4.36 ml of phosphorus trichloride and 40 ml of toluene , 16.48 g of 2-methyl-3-(4-chloro-2-methylphenyl)-5,6,7,8-tetrahydro-4(3H)-quinazolinone are obtained which melts at 151 - 153°C (after recrystallization from a 1:1 mixture of benzene and gasoline).

Eksempel 7 Example 7

Til en blanding av 2-acetamido-cyclohexen-carboxylsyre og 3,65 g isobutylamin i 90 ml toluen tilsettes en blanding av 2,18 ml fosfortriklorid og 20 ml toluen dråpevis under omrøring. Reaksjonsblandingen kokes under tilbakeløp i ytterligere 3 timer under omrøring og underkastes så dampdestillasjon.. Den utskilte olje ekstraheres derefter med 3 x 50 ml benzen, den erholdte benzenoppløsning tørres over kaliumcarbonat og inndampes. To a mixture of 2-acetamido-cyclohexene-carboxylic acid and 3.65 g of isobutylamine in 90 ml of toluene, a mixture of 2.18 ml of phosphorus trichloride and 20 ml of toluene is added dropwise while stirring. The reaction mixture is refluxed for a further 3 hours with stirring and then subjected to steam distillation. The separated oil is then extracted with 3 x 50 ml of benzene, the benzene solution obtained is dried over potassium carbonate and evaporated.

Residuum: 6,8 g av et harpiksaktig produkt.Residue: 6.8 g of a resinous product.

Det harpiksaktige produkt oppløses i 40 ml aceton, og opp-løsningen surgjøres med en 40%-ig vandig hydrogenbromidoppløs-ning. Til blandingen tilsettes ether inntil blakning. De ut-felte krystaller frafiltreres, vaskes med ether og tørres til konstant vekt. Man får 4,5 g 2-methyl-3-isobutyl-5,6,7,8-tetra-hydro-4(3H)-kinazolinon som smelter ved 218 - 221°C. The resinous product is dissolved in 40 ml of acetone, and the solution is acidified with a 40% aqueous hydrogen bromide solution. Ether is added to the mixture until pale. The precipitated crystals are filtered off, washed with ether and dried to constant weight. 4.5 g of 2-methyl-3-isobutyl-5,6,7,8-tetrahydro-4(3H)-quinazolinone is obtained which melts at 218 - 221°C.

Eksempel 8Example 8

4,98 g 2-methyl-5,6,7,8-tetrahydro-benzoxazin-4-on (frem-stilt fra 2-acetamido-cyclohexencarboxylsyre ved kokning med eddiksyreanhydrid og rensning ved destillasjon i vakuum) og 3,3 ml o-toluidin kokes ved 150 - 160°C i 5 timer.. Efter krystallisasjon fra en 1:1 blanding av benzen og bensin fåes 4,1 g 2-methyl-3-o-tolyl-5,6,7,8-tetrahydro-4(3H)-kinazolinon, som har de samme fysikalske og kjemiske egenskaper som produktet fra eksempel 2. Smeltepunkt: 150 - 153°C. 4.98 g of 2-methyl-5,6,7,8-tetrahydro-benzoxazin-4-one (prepared from 2-acetamido-cyclohexenecarboxylic acid by boiling with acetic anhydride and purification by distillation in vacuum) and 3.3 ml o -toluidine is boiled at 150 - 160°C for 5 hours. After crystallization from a 1:1 mixture of benzene and gasoline, 4.1 g of 2-methyl-3-o-tolyl-5,6,7,8-tetrahydro is obtained -4(3H)-quinazolinone, which has the same physical and chemical properties as the product from example 2. Melting point: 150 - 153°C.

Eksempel 9Example 9

Til en oppløsning av 17 g ethyl-2-oxo-cyclohexancarboxylat og 13,4 g N-fenylacetamidin i 75 ml absolutt alkohol får lov til å stå i 15 timer. Den inndampes så, og residuet krystalliseres fra en blanding av benzen og bensin. 17,1 g 2-methyl-3-fenyl-5,6,7,8-tetrahydro-4(3H)-kinazolinon fåes, som smelter ved A solution of 17 g of ethyl-2-oxo-cyclohexanecarboxylate and 13.4 g of N-phenylacetamidine in 75 ml of absolute alcohol is allowed to stand for 15 hours. It is then evaporated, and the residue is crystallized from a mixture of benzene and petrol. 17.1 g of 2-methyl-3-phenyl-5,6,7,8-tetrahydro-4(3H)-quinazolinone are obtained, which melts at

138 - 142°C. 138 - 142°C.

De fysikalske og kjemiske egenskaper av ovenstående produkt er identiske med dem for produktet fra eksempel 1. The physical and chemical properties of the above product are identical to those of the product from example 1.

Ved fremgangsmåten ifølge oppfinnelsen fremstilles: 2-methyl-3-fenyl-5,6,7,8-tetrahydro-4(3H)-kinazolinon og salter derav, The method according to the invention produces: 2-methyl-3-phenyl-5,6,7,8-tetrahydro-4(3H)-quinazolinone and salts thereof,

2-methyl-3-o-tolyl-5,6,7,8-tetrahydro-4(3H)-kinazolinon og salter derav, 2-methyl-3-o-tolyl-5,6,7,8-tetrahydro-4(3H)-quinazolinone and salts thereof,

2-methyl-3-p-ethylfenyl-5,6,7,8-tetrahydro-4(3H)-kinazolinon og salter derav,■ 2-methyl-3-p-ethylphenyl-5,6,7,8-tetrahydro-4(3H)-quinazolinone and salts thereof,■

2-methyl-3-o-klorfenyl-5,6,7,8-tetrahydro-4(3H)-kinazolinon og salter derav, 2-methyl-3-o-chlorophenyl-5,6,7,8-tetrahydro-4(3H)-quinazolinone and salts thereof,

2-methyl-3-(2-methyl-5-klorfenyl)-5,6,7,8-tetrahydro-4(3H)-kina-. zolinon og salter derav, 2-methyl-3-(2-methyl-5-chlorophenyl)-5,6,7,8-tetrahydro-4(3H)-quina-. zolinone and salts thereof,

2-methyl-3-(4-klor-2-methylfenyl)-5,6,7,8-tetrahydro-4(3H)-kinazolinon og salter derav,. 2-methyl-3-(4-chloro-2-methylphenyl)-5,6,7,8-tetrahydro-4(3H)-quinazolinone and salts thereof,.

2-methyl-3-(isobutyl)-5,6,7,8-tetrahydro-4(3H)-kinazolinon og salter derav, 2-methyl-3-(isobutyl)-5,6,7,8-tetrahydro-4(3H)-quinazolinone and salts thereof,

2-ethyl-3-o-tolyl-5,6,7,8-tetrahydro-4(3H)-kinazolinon og salter derav, 2-ethyl-3-o-tolyl-5,6,7,8-tetrahydro-4(3H)-quinazolinone and salts thereof,

2-ethyl-3-p-ethylfenyl-5,6,7,8-tetrahydro-4(3H)-kinazolinon.og salter derav, og 2-ethyl-3-p-ethylphenyl-5,6,7,8-tetrahydro-4(3H)-quinazolinone.and salts thereof, and

2-propyl-3-o-klor f enyl-5., 6,7, 8-te tr ahy dro-4 (3H) -kinazolinon og salter derav. 2-propyl-3-o-chlorophenyl-5, 6,7,8-trihydro-4 (3H)-quinazolinone and salts thereof.

Claims (4)

1. Fremgangsmåte ved fremstilling av 5,6,7,8-tetrahydro-4(3H)-kinazolinonderivater med den generelle formel: 1. Procedure for the preparation of 5,6,7,8-tetrahydro-4(3H)-quinazolinone derivatives with the general formula: hvor R er hydrogen eller alkyl med 1-5 carbonatomer, R 2 er alkyl med 1-5 carbonatomer, aryl som eventuelt er substituert med alkyl med 1-5 carbonatomer og/eller halogen, og salter derav, karakterisert ved ata) et amin med formelen: where R is hydrogen or alkyl with 1-5 carbon atoms, R 2 is alkyl with 1-5 carbon atoms, aryl which is optionally substituted with alkyl with 1-5 carbon atoms and/or halogen, and salts thereof, characterized by ata) an amine with the formula: hvor R 2er som ovenfor angitt, eller et salt derav, omsettes med et cyclohexencarboxylsyrederivat med formelen: where R 2 is as stated above, or a salt thereof, is reacted with a cyclohexenecarboxylic acid derivative with the formula: eller et benzoxazinonderivat med formelen: or a benzoxazinone derivative of the formula: hvorR^" er som ovenfor angitt, og R <3> er hydrogen eller alkyl med 1-5 carbonatomer, eller b) et alkyl-2-oxo-cyclohexancarboxylat med formelen: where R^" is as stated above, and R <3> is hydrogen or alkyl with 1-5 carbon atoms, or b) an alkyl-2-oxo-cyclohexanecarboxylate of the formula: hvor R er alkyl med 1-5 carbonatomer, omsettes med et amidinderivat med formelen: where R is alkyl with 1-5 carbon atoms, reacts with an amidine derivative with the formula: hvor R 1 og R <2> er som ovenfor angitt, eller med et salt derav, og eventuelt overføres en erholdt forbindelse med formel (I) til sitt salt med en uorganisk eller organisk syre.where R 1 and R <2> are as indicated above, or with a salt thereof, and optionally a compound of formula (I) obtained is transferred to its salt with an inorganic or organic acid. 2. Fremgangsmåte.ifølge krav 1, karakterisert ved at i fremgangsmåtevariant a) omsettes aminer med formel (II), hvor R 2er som ovenfor angitt, eller et salt derav, med carboxylsyrederivater med formel (III) i nærvær av et surt dehydratiseringsmiddel og toluen eller eddiksyre.2. Procedure according to claim 1, characterized in that in process variant a) amines of formula (II), where R 2 is as indicated above, or a salt thereof, are reacted with carboxylic acid derivatives of formula (III) in the presence of an acidic dehydrating agent and toluene or acetic acid. 3. Fremgangsmåte ifølge krav 1, karakterisert ved at i fremgangsmåtevariant a) 2 omsettes et amin med formelen (II), hvor R er som ovenfor angitt, eller et salt derav, med et benzoxazinonderivat med formel (IV) , hvor R" <*> " er som ovenfor angitt, i en smelte..3. Method according to claim 1, characterized by the fact that in method variant a) 2 react an amine with the formula (II), where R is as stated above, or a salt thereof, with a benzoxazinone derivative of formula (IV), where R" <*> " is as stated above, in a melt.. 4. Fremgangsmåte ifølge krav 1, karakterisert ved at i fremgangsmåtevariant b) utføres reaksjonen i en alkoholisk oppløsning.4. Method according to claim 1, characterized in that in method variant b) the reaction is carried out in an alcoholic solution.
NO793504A 1978-11-01 1979-10-31 PROCEDURE FOR THE PREPARATION OF 5,6,7,8-TETRAHYDRO-4 (3H) -KINAZOLINON DERIVATIVES NO793504L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU78CI1864A HU179687B (en) 1978-11-01 1978-11-01 Process for producing 5,6,7,8-- etrahydro-4-bracket-3h-bracket closed-quinasolinones

Publications (1)

Publication Number Publication Date
NO793504L true NO793504L (en) 1980-05-05

Family

ID=10994710

Family Applications (1)

Application Number Title Priority Date Filing Date
NO793504A NO793504L (en) 1978-11-01 1979-10-31 PROCEDURE FOR THE PREPARATION OF 5,6,7,8-TETRAHYDRO-4 (3H) -KINAZOLINON DERIVATIVES

Country Status (13)

Country Link
BE (1) BE879763A (en)
DD (1) DD146950A1 (en)
DE (1) DE2943568A1 (en)
DK (1) DK460379A (en)
ES (1) ES485333A1 (en)
FI (1) FI793403A (en)
FR (1) FR2440361A1 (en)
GB (1) GB2035316A (en)
HU (1) HU179687B (en)
NL (1) NL7907915A (en)
NO (1) NO793504L (en)
PL (1) PL219363A1 (en)
SE (1) SE7908991L (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191549B (en) * 1984-04-11 1987-03-30 Richter Gedeon Vegyeszet Process for producing 1-/6-/2 comma above-substituted-5 comma above, 6 comma above, 7 comma above, 8 comma above-tetrahydro-4 comma above-oxo-quinazolino//-3,4-dihydro-6,7-disubstituted-isoquinoline derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU172460B (en) * 1975-10-03 1978-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new 5,6-dihydro-3h-pyrimidin-4-one derivatives

Also Published As

Publication number Publication date
DE2943568A1 (en) 1980-05-14
HU179687B (en) 1982-11-29
DD146950A1 (en) 1981-03-11
GB2035316A (en) 1980-06-18
ES485333A1 (en) 1980-07-01
NL7907915A (en) 1980-05-06
SE7908991L (en) 1980-05-02
FI793403A (en) 1980-05-02
DK460379A (en) 1980-05-02
BE879763A (en) 1980-02-15
PL219363A1 (en) 1980-06-16
FR2440361A1 (en) 1980-05-30

Similar Documents

Publication Publication Date Title
US3303199A (en) Certain imidazolone derivatives and process for making same
NO151320B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRROLIDYLMETHYL-2-METOXY-4-AMINO-5-ISOPROPYL-SULPHONYL BENZAMIDES
US4299831A (en) 2-Trifluoromethyl-3-quinoline carboxamides, analgesic and anti-inflammatory compositions and methods employing them
NO874834L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TIENOPYRIDINONES.
NO153001B (en) SHIP DRIVING DEVICE
US3910922A (en) Novel trifluoromethyl-quinolines
US4232024A (en) 1-Oxo-1H-pyrimido[6,1-b]benzthiazole derivatives
CA1122216A (en) 7-methylthio or methylsulfinyl-5-oxo-5h-thiazolo- [2,3-b] quinazoline-2-carboxylic acid
NO845169L (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZIMIDAZOLE DERIVATIVES
CA1075237A (en) Purine derivatives
NO793504L (en) PROCEDURE FOR THE PREPARATION OF 5,6,7,8-TETRAHYDRO-4 (3H) -KINAZOLINON DERIVATIVES
EP0055068A1 (en) Quinolone derivatives and their use as pharmaceuticals
US4261997A (en) 4-Alkyl-pyrazolo[5,1-b]-quinazolin-9(4H)-ones and anti-allergic compositions containing them
US3306909A (en) 3-carbamoyl-1,5-diphenyl-2,4-pyrrolidinediones
CA1044237A (en) Triazolo isoquinoline derivatives
US3644368A (en) Novel quinolines
US2906757A (en) Their preparation
EP0015065B1 (en) Pyrazolo (5,1-b) quinazolin-9(4h)-one derivatives, process for their preparation and pharmaceutical compositions containing them
US6576764B2 (en) Synthesis and crystallization of piperazine ring-containing compounds
US2701251A (en) Process of producing indoleacetic acids and new indoleacetic acids produced thereby
EP0076559B1 (en) Antiallergic imidosulfamides
IE41673B1 (en) Fused pyrimidines and preparation thereof
US3433801A (en) 1-aryl-3-(n-lower alkyl amino) pyrrolidines
EP0165592A2 (en) Antitumor agents
IE42746B1 (en) Fused pyrimidine-4-(3h)-ones and preparation thereof